Clinical Trial Update: Study of ATN-224 in Patients With Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating ATN-224 in patients with prostate cancer; status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• ATN-224

Snippet

Sponsor: Attenuon | Conditions: Prostate Cancer | Phase 2 | Status: UNKNOWN